Collector
Zealand Pharma shares drop 25% after a quarter of patients quit obesity drug trial | Collector
Reuters

Zealand Pharma shares drop 25% after a quarter of patients quit obesity drug trial

Zealand Pharma shares drop 25% after a quarter of patients quit obesity drug trial

Go to News Site